bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics
Labor Berlin and bioMérieux announce the signature of an agreement to create a Center of Excellence for microbiology and enhanced laboratory automation. The center will be located at Europe’s largest hospital laboratory, serving more than 8,000 in-house patients in Berlin and handling over 23 million patient analyses a year.
Ipsen and bioMérieux enter into a broad partnership in personalized medicine
The two companies leverage combined expertise in therapeutics and in diagnostics to improve patient care
bioTheranostics’ Breast Cancer IndexSM predicts risk for late recurrence in early stage ER-positive breast cancer patients
bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company’s Breast Cancer Index (BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
Lab Informatics Expert Joins bioMérieux
A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology.